Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Changes in Exhaled 13CO2/12CO2 Breath Delta Value as an Early Indicator of Infection in ICU Patients

NCT02327130 is registered in ClinicalTrials.gov with Isomark, LLC as lead sponsor.

NCT NCT02327130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02327130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Changes in Exhaled 13CO2/12CO2 Breath Delta Value as an Early Indicator of Infection in ICU Patients
Lead sponsor
Isomark, LLC
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2015
Completion date
December 31, 2017
Enrollment
32 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis